{
    "organizations": [],
    "uuid": "6e255e6d320b0e486ef30c3f4233ea713582ccfb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-adverum-biotechnologies-reports-q1/brief-adverum-biotechnologies-reports-q1-loss-per-share-0-30-idUSASC0A11N",
    "ord_in_thread": 0,
    "title": "BRIEF-Adverum Biotechnologies Reports Q1 Loss Per Share $0.30",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Adverum Biotechnologies Inc:\n* ADVERUM BIOTECHNOLOGIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q1 LOSS PER SHARE $0.30 * Q1 EARNINGS PER SHARE VIEW $-0.29 â€” THOMSON REUTERS I/B/E/S\n* ADVERUM BIOTECHNOLOGIES- REVENUES, CONSISTING OF REVENUE FROM COLLABORATIVE RESEARCH, WERE $0.2 MILLION FOR 3 MONTHS ENDED MARCH 31, 2018, VERSUS $0.5 MILLION LAST YEAR Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:07:00.000+03:00",
    "crawled": "2018-05-10T17:40:01.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "adverum",
        "biotechnology",
        "inc",
        "adverum",
        "biotechnology",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "adverum",
        "revenue",
        "consisting",
        "revenue",
        "collaborative",
        "research",
        "million",
        "month",
        "ended",
        "march",
        "versus",
        "million",
        "last",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}